Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06538883Not ApplicableRecruiting

Sedation in ICU Patients With Mechanical Ventilation

Role: collaborator

NCT07082881Not ApplicableNot Yet Recruiting

Impact of Colostrum Oropharyngeal Immunotherapy on Postnatal Growth in Preterm Infants

Role: lead

NCT05930444Completed

Multimodal Machine Learning for Auxiliary Diagnosis of Eye Diseases

Role: collaborator

NCT04033861Phase 4Unknown

Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI

Role: collaborator

NCT04251286Unknown

Screening and Follow-up Study of Neonatal Jaundice Based on Mobile Network

Role: collaborator

All 5 trials loaded